Key points are not available for this paper at this time.
Protein–protein interactions (PPIs) play a critical role in cellular signaling and represent interesting targets for therapeutic intervention. 14-3-3 proteins integrate many signaling targets via PPIs and are frequently implicated in disease, making them intriguing drug targets. Here, we review the recent advances in the 14-3-3 field. It will discuss the roles 14-3-3 proteins play within the cell, elucidation of their expansive interactome, and the complex mechanisms that underpin their function. In addition, the review will discuss significant advances in the development of molecular glues that target 14-3-3 PPIs. In particular, it will focus on novel drug discovery and development methodologies that have delivered selective, potent, and drug-like molecules that could open new avenues for the development of precision molecular tools and medicines.
Building similarity graph...
Analyzing shared references across papers
Loading...
Paulo Pitasse-Santos
University of Leicester
Isaac Hewitt-Richards
University of Leicester
Malsha D. Abeywickrama Wijewardana Sooriyaarachchi
University of Leicester
Current Opinion in Structural Biology
University of Leicester
Building similarity graph...
Analyzing shared references across papers
Loading...
Pitasse-Santos et al. (Sun,) studied this question.
synapsesocial.com/papers/68e6d2e5b6db643587650909 — DOI: https://doi.org/10.1016/j.sbi.2024.102822
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: